Integrative Analysis of Exosome-Mediated Single-Cell Transcriptomics and Proteomics in Gastric Cardia Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is an observational study with a case control design. This study included patients with gastric cancer confirmed by pathological diagnosis of gastric tissue, and matched the control population according to age, gender, etc. In this study, researchers collected clinical information and multiple biological samples such as serum and tissue tissue from the study subjects. The researchers combined exosome sequencing, proteomics and single-cell RNA sequencing to explore the heterogeneity of cardia cancer, identify specific biomarkers and potential therapeutic targets for cardia cancer, and provide a basis for the development of new diagnostic tools and therapeutic strategies.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Potwierdzony rak żołądka (badaniem endoskopowym i testami laboratoryjnymi)
- •Podpisana zgoda na udział w badaniu
✗ Disqualifies
- •Operacja żołądka lub jelit w ciągu ostatniego roku
- •Chemioterapia przed operacją w ostatnim czasie
- •Stosowanie inhibitorów pompy protonowej, antybiotyków, probiotyków lub prebiotyków przez ostatni miesiąc
- •Hormonoterapia w ostatnim czasie
- •Choroby zakaźne lub inne choroby jelit (np. zapalenie jelit, zespół jelita drażliwego)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 3, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Qilu Hospital of Shandong University
Jinan, China
Trial contact
Xiaoya Wang, Bachelor
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/4/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.